Categories Health Care, Markets

Why Amarin stock is rallying today

Amarin Corporation (NASDAQ: AMRN) shares got a major boost during the pre-market hours of Thursday after it said the American Diabetes Association (ADA) has noted updates related to the results of its REDUCE-IT study in the annual Standards of Medical Care in Diabetes report.

AMRN shares jumped 9.5% during the morning trade. The stock has gained 38% since the beginning of this year.

Image for representation (Photo by Drew Hays on Unsplash)

The ADA is a non-profit organization that works to spread awareness about diabetes, besides raising funds for researches taking place in this field.  As a general policy, the organization does not endorse or certify any specific brands.

ADA’s findings relate to icosapent ethyl, which Amarin markets under the brand name Vascepa capsules. Vascepa has received FDA approval to cut down triglyceride levels in adult patients. The Dublin, Ireland-based firm has, meanwhile, commenced transmission of data to the FDA seeking an expansion of the Vascepa FDA label based on the landmark REDUCE-IT results.

READ: AMARIN SHARES JUMP ON RUMORS OVER NOVARTIS INTEREST

The FDA is yet to review this application, but investors are hoping that ADA’s reference would now help fast-track the process.

In the Standard of Care recommendation, ADA notes, “…based on the outcome of Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT), which determined the addition of icosapent ethyl to statin therapy for patients with high triglyceride levels reduced cardiovascular events.”

READ: WHAT IS NASH AND WHICH BIOTECH FIRMS ARE VYING FOR THE FIRST-MOVER STATUS

Meanwhile, it also added, “It should be noted that data are lacking with other omega-3 fatty acids, and results of the REDUCE-IT trial should not be extrapolated to other products.”

Earlier last month, shares of Amarin Corp rallied 14% on rumors that Novartis (NVS) is looking to buy the Dublin-based firm. There have been no further updates on the same.

 

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

 

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

Leave a Reply

Your email address will not be published. Required fields are marked *

Add Comment
Loading...

Cancel
Viewing Highlight
Loading...
Highlight
Close
Top